🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Mirum Pharmaceuticals, Inc.

MIRM Healthcare
$102.24 +$1.37 (1.36%)
Market Cap: $6.64 B
Gurus Holding
5
Popularity Rank
#1934
% of Shares Held
0.92%
Net Activity (Q2 2026)
-$46.53 M

Guru Ownership Trend

Guru Analysis for Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals, Inc. (MIRM), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $60.83 M.

Top institutional holders include Renaissance Technologies (RenTech) and Ken Fisher.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $46.53 M net outflow during the quarter.

Recent activity highlights Jefferies Group who increased their stake by 361.9%. Conversely, Joel Greenblatt reduced exposure by 24.1%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$3.6 M
Total Buy Value
New Buys 0
Additions 1
-$50.13 M
Total Sell Value
Reductions 4
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
5
Net Buyers
1

FAQs for Mirum Pharmaceuticals, Inc. (MIRM)

Major holders include Renaissance Technologies (RenTech) ($51.77 M), Ken Fisher ($9.66 M), Jefferies Group ($4.6 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 594,953 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $46.53 M, with 1 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 4 managers trimmed their positions, while 1 fully exited MIRM. The total reported sell value was $50.13 M.

Yes, 0 managers opened new positions in MIRM, and 1 increased their existing holdings. The total reported buy value was $3.6 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.07% Reduce -24.0% 442,185 $51.77 M Q2 2026
0.00% Reduce -11.4% 82,476 $9.66 M Q2 2026
0.03% Add 361.9% 39,260 $4.6 M Q2 2026
0.00% Reduce -9.9% 28,647 $3.35 M Q2 2026
0.00% Reduce -24.1% 2,385 $279,212 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form